
Podcast Episode 129: Aspirin-Exacerbated Respiratory Disease (AERD)
This is a recorded episode of the AAAAI podcast series, Conversations from the World of Allergy. Tanya M. Laidlaw, MD FAAAAI, offers comprehensive information on how to diagnose and manage AERD.
To listen to the podcast episode, CLICK HERE.
If you have listened to the podcast and would like to receive CME, click on the Register tab and then complete the assessment.
Target Audience
- Allergist/immunologists
- Fellows-in-Training
- Nurses and Nurse Practitioners
- Physician Assistants and Other Allied Health Professionals
Learning Objectives
Upon completion of this activity, participants should be able to:
- Discuss the pathophysiology of AERD
- Outline other factors such as alcohol and diet that can contribute to AERD symptoms
- Explore the pros and cons of current therapies including aspirin desensitization and biologics
The information disclosed by the speakers and planning committee was reviewed in accordance with the AAAAI Disclosure Policy. All relevant financial relationships were mitigated by the planners, faculty, and reviewers prior to their participation in the development of this activity.
Planning Committee
Rebecca R. Saff, MD PhD FAAAAI
Massachusetts General Hospital
Relevant relationships: None
Faculty
Tanya M. Laidlaw, MD FAAAAI
Harvard Medical School
Relevant relationships: None
Content Reviewers
Stuart L. Abramson, MD PhD AE-C FAAAAI
Shannon Medical Center/Shannon Clinic
Relevant relationships: None
AAAAI DISCLOSURE POLICY
Pursuant to the Code of Ethics for the American Academy of Allergy, Asthma & Immunology (AAAAI) and the Standards for Commercial Support of Continuing Medical Education of the Accreditation Council for Continuing Medical Education, the AAAAI requires disclosure of certain information from faculty members of educational activities designated for CME credit by the AAAAI. Prior to the activity, authors and reviewers are required to disclose all relationships that meet the following parameters:
- Employment. Name of employer and job title.
- Financial interests. All organizations, other than the employer, from which the faculty member or a member of his/her immediate family or household receives annual remuneration in any amount (including grants, honoraria and consulting fees).
- Research interests. All organizations which support research projects for which the faculty member or member of his/her immediate family or household serves as an investigator.
- Legal Consultation Services/Expert Witness Testimony: All topics on which the faculty member provided legal consultation and/or expert witness testimony during the previous calendar year.
- Organizational interests: All organizations, other than the AAAAI, for which the faculty member holds volunteer positions.
- Gifts. All organizations from which the faculty member or a member of his/her immediate family or household have received a gift of any amount in the last year.
- Other interests. All interests of the faculty member or a member of his/her immediate family or household that would be judged by a majority of his/her peers to be more than casual and/or likely to impact his/her ability to exercise independent judgment. This includes any financial interest in or relationship with any manufacturer of a commercial product, and any financial interest or relationship with any organization that provides commercial support to AAAAI-sponsored educational activities.
The information disclosed by the speakers and planning committee was reviewed in accordance with the AAAAI Disclosure Policy. All potential conflicts of interest were resolved by the planners, faculty, and reviewers prior to their participation in the development of this activity.
ACCREDITATION STATEMENT
The American Academy of Allergy, Asthma and Immunology (AAAAI) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
DESIGNATION STATEMENT
The American Academy of Allergy, Asthma & Immunology designates this enduring material for a maximum of .75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CREDIT CLAIMING PERIOD
Credit claiming for this activity will expire at 11:59 pm on February 28, 2026. Requests to claim credit on or after March 01, 2026 will be subject to an administrative fee.
AAAAI PRIVACY POLICY
To verify your participation in educational activities, you may be asked to provide your name, contact information, and/or other descriptors. The AAAAI will not release this information to outside entities. It may be used internally to inform you of other AAAAI educational activities. If you wish to have your information excluded from this process, please contact us at [email protected].
QUESTIONS
Activity related questions should be directed to [email protected].
Available Credit
- 0.75 AttendanceAttendance credit.
- 0.75 CMECME credit.